Skip to main content
. 2025 Jul 18;26(14):6896. doi: 10.3390/ijms26146896
AKT protein kinase B
BAP1 BRCA1-associated protein 1
BCL2 B-cell lymphoma 2
BID BH3-interacting domain death agonist
BIM B-cell lymphoma 2-like protein 11
CDK cyclin-dependent kinases
cIAP1 cellular inhibitor of apoptosis 1
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
ELISA enzyme-linked immunosorbent assay
G1 phase gap1 phase
GLOBOCAN Global Cancer Observatory: Cancer Today
GO gene ontology
HIF hypoxia-inducible factor
KEGG Kyoto Encyclopedia of Genes and Genomes
MCL1 myeloid cell leukemia sequence 1
MCRS1 microspherule protein 1
MET MET proto-oncogene, receptor tyrosine kinase
MLL3 mixed lineage leukemia 3
MOMP mitochondrial outer membrane permeability
mRCC metastatic renal cell carcinoma
MST1 mammalian sterile 20-like protein kinase 1
mTOR mammalian target of rapamycin
MTT assay 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide assay
NF-κB nuclear factor kappa B
NSAIDs non-steroidal anti-inflammatory drugs
PARP poly (ADP-ribose) polymerase
PBRM1 polybromo 1
PBS phosphate-buffered saline
PD-1 programmed cell death protein 1
PD-L1 programmed cell death ligand 1
PI3K phosphatidylinositol 3-kinase
pRB retinoblastoma protein
PTEN phosphatase and tensin homolog
PUMA p53 upregulated modulator of apoptosis
RCC renal cell carcinoma
RNA ribonucleic acid
ROS reactive oxygen species
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis
SEER Surveillance, Epidemiology, and End Results
SETD2 SET domain containing 2, histone lysine methyltransferase
STAT3 signal transducer and activator of transcription 3
S phase synthesis phase
TEAD transcriptional enhanced associated domain
TP53 tumor protein p53
UGTs uridine diphosphate glycosyltransferases
YAP yes-associated protein